133 related articles for article (PubMed ID: 36482201)
1. Tumour-derived exosomal piR-25783 promotes omental metastasis of ovarian carcinoma by inducing the fibroblast to myofibroblast transition.
Li G; Yi X; Du S; Gong L; Wu Q; Cai J; Sun S; Cao Y; Chen L; Xu L; Wang Z
Oncogene; 2023 Feb; 42(6):421-433. PubMed ID: 36482201
[TBL] [Abstract][Full Text] [Related]
2. The metastatic phenotype shift toward myofibroblast of adipose-derived mesenchymal stem cells promotes ovarian cancer progression.
Tang H; Chu Y; Huang Z; Cai J; Wang Z
Carcinogenesis; 2020 Apr; 41(2):182-193. PubMed ID: 31046126
[TBL] [Abstract][Full Text] [Related]
3. Exosomes from Human Omental Adipose-Derived Mesenchymal Stem Cells Secreted into Ascites Promote Peritoneal Metastasis of Epithelial Ovarian Cancer.
Qu Q; Liu L; Cui Y; Chen Y; Wang Y; Wang Y
Cells; 2022 Oct; 11(21):. PubMed ID: 36359787
[TBL] [Abstract][Full Text] [Related]
4. Pro-tumoral behavior of omental adipocyte-derived fibroblasts in tumor microenvironment at the metastatic site of ovarian cancer.
Iyoshi S; Yoshihara M; Nakamura K; Sugiyama M; Koya Y; Kitami K; Uno K; Mogi K; Tano S; Tomita H; Kajiwara K; Taki M; Yamaguchi S; Nawa A; Kajiyama H
Int J Cancer; 2021 Dec; 149(11):1961-1972. PubMed ID: 34469585
[TBL] [Abstract][Full Text] [Related]
5. Blockage of transdifferentiation from fibroblast to myofibroblast in experimental ovarian cancer models.
Yao Q; Qu X; Yang Q; Good DA; Dai S; Kong B; Wei MQ
Mol Cancer; 2009 Sep; 8():78. PubMed ID: 19781102
[TBL] [Abstract][Full Text] [Related]
6. Smad7 blocks transforming growth factor-β1-induced gingival fibroblast-myofibroblast transition via inhibitory regulation of Smad2 and connective tissue growth factor.
Sobral LM; Montan PF; Zecchin KG; Martelli-Junior H; Vargas PA; Graner E; Coletta RD
J Periodontol; 2011 Apr; 82(4):642-51. PubMed ID: 21054221
[TBL] [Abstract][Full Text] [Related]
7. A loop of cancer-stroma-cancer interaction promotes peritoneal metastasis of ovarian cancer via TNFα-TGFα-EGFR.
Lau TS; Chan LK; Wong EC; Hui CW; Sneddon K; Cheung TH; Yim SF; Lee JH; Yeung CS; Chung TK; Kwong J
Oncogene; 2017 Jun; 36(25):3576-3587. PubMed ID: 28166193
[TBL] [Abstract][Full Text] [Related]
8. CLIC4 mediates TGF-beta1-induced fibroblast-to-myofibroblast transdifferentiation in ovarian cancer.
Yao Q; Qu X; Yang Q; Wei M; Kong B
Oncol Rep; 2009 Sep; 22(3):541-8. PubMed ID: 19639201
[TBL] [Abstract][Full Text] [Related]
9. Fibroblasts in omentum activated by tumor cells promote ovarian cancer growth, adhesion and invasiveness.
Cai J; Tang H; Xu L; Wang X; Yang C; Ruan S; Guo J; Hu S; Wang Z
Carcinogenesis; 2012 Jan; 33(1):20-9. PubMed ID: 22021907
[TBL] [Abstract][Full Text] [Related]
10. Ovarian tumor cell-derived JAGGED2 promotes omental metastasis through stimulating the Notch signaling pathway in the mesothelial cells.
Islam SS; Al-Mohanna FH; Yousef IM; Al-Badawi IA; Aboussekhra A
Cell Death Dis; 2024 Apr; 15(4):247. PubMed ID: 38575576
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta1, transforming growth factor-beta2, and transforming growth factor-beta3 enhance ovarian cancer metastatic potential by inducing a Smad3-dependent epithelial-to-mesenchymal transition.
Do TV; Kubba LA; Du H; Sturgis CD; Woodruff TK
Mol Cancer Res; 2008 May; 6(5):695-705. PubMed ID: 18505915
[TBL] [Abstract][Full Text] [Related]
12. Exosomal ANXA2 derived from ovarian cancer cells regulates epithelial-mesenchymal plasticity of human peritoneal mesothelial cells.
Gao L; Nie X; Gou R; Hu Y; Dong H; Li X; Lin B
J Cell Mol Med; 2021 Dec; 25(23):10916-10929. PubMed ID: 34725902
[TBL] [Abstract][Full Text] [Related]
13. Stromal POSTN induced by TGF-β1 facilitates the migration and invasion of ovarian cancer.
Yue H; Li W; Chen R; Wang J; Lu X; Li J
Gynecol Oncol; 2021 Feb; 160(2):530-538. PubMed ID: 33317907
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor β1 signaling coincides with epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis in mice.
Shen M; Liu X; Zhang H; Guo SW
Hum Reprod; 2016 Feb; 31(2):355-69. PubMed ID: 26689216
[TBL] [Abstract][Full Text] [Related]
15. The activated transforming growth factor-beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer.
Yamamura S; Matsumura N; Mandai M; Huang Z; Oura T; Baba T; Hamanishi J; Yamaguchi K; Kang HS; Okamoto T; Abiko K; Mori S; Murphy SK; Konishi I
Int J Cancer; 2012 Jan; 130(1):20-8. PubMed ID: 21503873
[TBL] [Abstract][Full Text] [Related]
16. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
Cho N; Razipour SE; McCain ML
Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
[TBL] [Abstract][Full Text] [Related]
17. Micro-RNA-21 regulates TGF-β-induced myofibroblast differentiation by targeting PDCD4 in tumor-stroma interaction.
Yao Q; Cao S; Li C; Mengesha A; Kong B; Wei M
Int J Cancer; 2011 Apr; 128(8):1783-92. PubMed ID: 20533548
[TBL] [Abstract][Full Text] [Related]
18. Mesothelial-to-mesenchymal transition as a possible therapeutic target in peritoneal metastasis of ovarian cancer.
Rynne-Vidal A; Au-Yeung CL; Jiménez-Heffernan JA; Pérez-Lozano ML; Cremades-Jimeno L; Bárcena C; Cristóbal-García I; Fernández-Chacón C; Yeung TL; Mok SC; Sandoval P; López-Cabrera M
J Pathol; 2017 Jun; 242(2):140-151. PubMed ID: 28247413
[TBL] [Abstract][Full Text] [Related]
19. Carcinoma-associated fibroblasts derive from mesothelial cells via mesothelial-to-mesenchymal transition in peritoneal metastasis.
Sandoval P; Jiménez-Heffernan JA; Rynne-Vidal Á; Pérez-Lozano ML; Gilsanz Á; Ruiz-Carpio V; Reyes R; García-Bordas J; Stamatakis K; Dotor J; Majano PL; Fresno M; Cabañas C; López-Cabrera M
J Pathol; 2013 Dec; 231(4):517-31. PubMed ID: 24114721
[TBL] [Abstract][Full Text] [Related]
20. KDM6B promotes ovarian cancer cell migration and invasion by induced transforming growth factor-β1 expression.
Liang S; Yao Q; Wei D; Liu M; Geng F; Wang Q; Wang YS
J Cell Biochem; 2019 Jan; 120(1):493-506. PubMed ID: 30277596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
